Occam Recruits Chief Commercial Officer at Geron
In September 2024, Occam Global recruited Jim Ziegler as Chief Commercial Officer of Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical oncology company.
In this role, Ziegler will spearhead the company’s global commercial strategy and operations and drive the growth of RYTELO™, Geron’s first marketed product.
Ziegler has over 25 years of commercial experience in the biopharmaceutical industry, spanning strategic and operational leadership roles in large and smaller organizations.
Ziegler joins Geron from Iovance Biotherapeutics (Nasdaq:IOVA), where he served as Executive Vice President of Commercial, with global responsibilities for the company’s novel autologous cell therapy program and led the U.S. commercial launch of Amtagvi™. Previously, he served in numerous commercial leadership roles at Gilead, Biogen, Amgen, and Pfizer.
Prior to the biopharmaceutical industry, Jim honorably served his country as an Armor Officer in the U.S. Army. Ziegler received a B.S. from the United States Military Academy at West Point and an M.B.A. from the University of Chicago.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.